0001415889-22-011004.txt : 20221102 0001415889-22-011004.hdr.sgml : 20221102 20221102163220 ACCESSION NUMBER: 0001415889-22-011004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BILBREY JOHN P CENTRAL INDEX KEY: 0001268386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 221354641 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 form4-11022022_011109.xml X0306 4 2022-10-31 0001739104 Elanco Animal Health Inc ELAN 0001268386 BILBREY JOHN P C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 true false false false Deferred Stock Units 2022-10-31 4 A 0 669.699 13.19 A Common Stock 669.699 13078.1399 D Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022. /s/ Marcela A. Kirberger, as Attorney-in-Fact for John P. Bilbrey 2022-11-02